ASPP1 deficiency promotes epithelial-mesenchymal transition, invasion and metastasis in colorectal cancer

Autor: Yanmei Zou, Xin Lu, Hua Xiong, Yilu Zhou, Dian Liu, Yihua Wang, Xianglin Yuan, Charlotte Hill, Ayse Ertay, Hong Qiu, Juanjuan Li, Rob M. Ewing
Jazyk: angličtina
Rok vydání: 2020
Předmět:
Male
0301 basic medicine
Cancer Research
Epithelial-Mesenchymal Transition
Colorectal cancer
Immunology
Mice
Nude

Article
Metastasis
Mice
03 medical and health sciences
Cellular and Molecular Neuroscience
0302 clinical medicine
Downregulation and upregulation
In vivo
Cell Line
Tumor

medicine
Animals
Humans
Neoplasm Invasiveness
Cell migration
Epithelial–mesenchymal transition
Neoplasm Metastasis
lcsh:QH573-671
Adaptor Proteins
Signal Transducing

Neoplasm Staging
Cancer
Tissue microarray
business.industry
lcsh:Cytology
Signal transducing adaptor protein
Cell Biology
Middle Aged
HCT116 Cells
medicine.disease
digestive system diseases
030104 developmental biology
Apoptosis
030220 oncology & carcinogenesis
Cancer research
Heterografts
Female
Apoptosis Regulatory Proteins
Colorectal Neoplasms
business
Zdroj: Cell Death and Disease, Vol 11, Iss 4, Pp 1-13 (2020)
Cell Death & Disease
ISSN: 2041-4889
Popis: The apoptosis-stimulating protein of p53 (ASPP) family of proteins can regulate apoptosis by interacting with the p53 family and have been identified to play an important role in cancer progression. Previously, we have demonstrated that ASPP2 downregulation can promote invasion and migration by controlling β-catenin- dependent regulation of ZEB1, however, the role of ASPP1 in colorectal cancer (CRC) remains unclear. We analyzed data from The Cancer Genome Atlas (TCGA) and coupled this to in vitro experiments in CRC cell lines as well as to experimental pulmonary metastasis in vivo. Tissue microarrays of CRC patients with information of clinical-pathological parameters were also used to investigate the expression and function of ASPP1 in CRC. Here, we report that loss of ASPP1 is capable of enhancing migration and invasion in CRC, both in vivo and in vitro. We demonstrate that depletion of ASPP1 could activate expression of Snail2 via the NF-κB pathway and in turn, induce EMT; and this process is further exacerbated in RAS-mutated CRC. ASPP1 could be a prognostic factor in CRC, and the use of NF-κB inhibitors may provide new strategies for therapy against metastasis in ASPP1-depleted CRC patients.
Databáze: OpenAIRE